{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:37:29Z","timestamp":1793957849671,"version":"4.8.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"Importance<\/jats:title>Preoperative stereotactic radiosurgery (SRS) has been demonstrated as a feasible alternative to postoperative SRS for resectable brain metastases (BMs) with potential benefits in adverse radiation effects (AREs) and meningeal disease (MD). However, mature large-cohort multicenter data are lacking.<\/jats:p><\/jats:sec>Objective<\/jats:title>To evaluate preoperative SRS outcomes and prognostic factors from a large international multicenter cohort (Preoperative Radiosurgery for Brain Metastases\u2013PROPS-BM).<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This multicenter cohort study included patients with BMs from solid cancers, of which at least 1 lesion received preoperative SRS and a planned resection, from 8 institutions. Radiosurgery to synchronous intact BMs was allowed. Exclusion criteria included prior or planned whole-brain radiotherapy and no cranial imaging follow-up. Patients were treated between 2005 and 2021, with most treated between 2017 and 2021.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Preoperative SRS to a median dose to 15 Gy in 1 fraction or 24 Gy in 3 fractions delivered at a median (IQR) of 2 (1-4) days before resection.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary end points were cavity local recurrence (LR), MD, ARE, overall survival (OS), and multivariable analysis of prognostic factors associated with these outcomes.<\/jats:p><\/jats:sec>Results<\/jats:title>The study cohort included 404 patients (214 women [53%]; median [IQR] age, 60.6 [54.0-69.6] years) with 416 resected index lesions. The 2-year cavity LR rate was 13.7%. Systemic disease status, extent of resection, SRS fractionation, type of surgery (piecemeal vs en bloc), and primary tumor type were associated with cavity LR risk. The 2-year MD rate was 5.8%, with extent of resection, primary tumor type, and posterior fossa location being associated with MD risk. The 2-year any-grade ARE rate was 7.4%, with target margin expansion greater than 1 mm and melanoma primary being associated with ARE risk. Median OS was 17.2 months (95% CI, 14.1-21.3 months), with systemic disease status, extent of resection, and primary tumor type being the strongest prognostic factors associated with OS.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this cohort study, the rates of cavity LR, ARE, and MD after preoperative SRS were found to be notably low. Several tumor and treatment factors were identified that are associated with risk of cavity LR, ARE, MD, and OS after treatment with preoperative SRS. A phase 3 randomized clinical trial of preoperative vs postoperative SRS (NRG BN012) has began enrolling (NCT05438212).<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaoncol.2023.1629","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T15:00:47Z","timestamp":1686236447000},"page":"1066","source":"Crossref","is-referenced-by-count":36,"title":["Risk Factors for Progression and Toxic Effects After Preoperative Stereotactic Radiosurgery for Patients With Resected Brain Metastases"],"prefix":"10.1001","volume":"9","author":[{"given":"Roshan S.","family":"Prabhu","sequence":"first","affiliation":[{"name":"Levine Cancer Institute, Atrium Health, Charlotte, North Carolina"},{"name":"Southeast Radiation Oncology Group, Charlotte, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobi","family":"Akinyelu","sequence":"additional","affiliation":[{"name":"Levine Cancer Institute, Atrium Health, Charlotte, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary K.","family":"Vaslow","sequence":"additional","affiliation":[{"name":"Cone Health Cancer Center, Greensboro, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Matsui","sequence":"additional","affiliation":[{"name":"The Ohio State University College of Medicine, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Haghighi","sequence":"additional","affiliation":[{"name":"Peter McCallum Cancer Centre, Melbourne, Victoria, Australia"},{"name":"Icon Cancer Centre, Epworth Centre, Richmond, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu","family":"Dan","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark V.","family":"Mishra","sequence":"additional","affiliation":[{"name":"University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin S.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Boyles","sequence":"additional","affiliation":[{"name":"Cone Health Cancer Center, Greensboro, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley K.","family":"Perlow","sequence":"additional","affiliation":[{"name":"The Ohio State University College of Medicine, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Palmer","sequence":"additional","affiliation":[{"name":"The Ohio State University College of Medicine, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Udovicich","sequence":"additional","affiliation":[{"name":"Peter McCallum Cancer Centre, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toral R.","family":"Patel","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zabi","family":"Wardak","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme F.","family":"Woodworth","sequence":"additional","affiliation":[{"name":"University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Ksendzovsky","sequence":"additional","affiliation":[{"name":"University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailin","family":"Yang","sequence":"additional","affiliation":[{"name":"Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel T.","family":"Chao","sequence":"additional","affiliation":[{"name":"Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony L.","family":"Asher","sequence":"additional","affiliation":[{"name":"Levine Cancer Institute, Atrium Health, Charlotte, North Carolina"},{"name":"Carolina Neurosurgery and Spine Associates, Charlotte, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart H.","family":"Burri","sequence":"additional","affiliation":[{"name":"Levine Cancer Institute, Atrium Health, Charlotte, North Carolina"},{"name":"Southeast Radiation Oncology Group, Charlotte, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"coi230020r1","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","article-title":"Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.","volume":"18","author":"Mahajan","year":"2017","journal-title":"Lancet Oncol"},{"issue":"8","key":"coi230020r2","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","article-title":"Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): a multicentre, randomised, controlled, phase 3 trial.","volume":"18","author":"Brown","year":"2017","journal-title":"Lancet Oncol"},{"key":"coi230020r3","doi-asserted-by":"publisher","DOI":"10.3171\/2018.7.JNS181293","article-title":"Preoperative stereotactic radiosurgery before planned resection of brain metastases: updated analysis of efficacy and toxicity of a novel treatment paradigm.","author":"Prabhu","journal-title":"J Neurosurg"},{"issue":"3","key":"coi230020r4","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ijrobp.2021.05.124","article-title":"Preoperative radiosurgery for resected brain metastases: the PROPS-BM multicenter cohort study.","volume":"111","author":"Prabhu","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"coi230020r5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1227\/NEU.0000000000001096","article-title":"Comparing preoperative with postoperative stereotactic radiosurgery for resectable brain metastases: a multi-institutional analysis.","volume":"79","author":"Patel","year":"2016","journal-title":"Neurosurgery"},{"issue":"3","key":"coi230020r6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/cancers11030294","article-title":"Pre-operative versus post-operative radiosurgery of brain metastases-volumetric and dosimetric impact of treatment sequence and margin concept.","volume":"11","author":"El Shafie","year":"2019","journal-title":"Cancers (Basel)"},{"key":"coi230020r7","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2022.07.019","article-title":"Pre-operative stereotactic radiosurgery for cerebral metastatic disease: a retrospective dose-volume study.","author":"Bugarini","year":"2022","journal-title":"Radiother Oncol"},{"issue":"2","key":"coi230020r8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11060-022-04073-w","article-title":"Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysis.","volume":"159","author":"Palmer","year":"2022","journal-title":"J Neurooncol"},{"issue":"4","key":"coi230020r9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1227\/ONS.0000000000000101","article-title":"From postoperative to preoperative: a case series of hypofractionated and single-fraction neoadjuvant stereotactic radiosurgery for brain metastases.","volume":"22","author":"Udovicich","year":"2022","journal-title":"Oper Neurosurg (Hagerstown)"},{"issue":"2","key":"coi230020r10","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijrobp.2011.12.009","article-title":"Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control.","volume":"84","author":"Choi","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"coi230020r11","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ijrobp.2017.09.047","article-title":"Consensus contouring guidelines for postoperative completely resected cavity stereotactic radiosurgery for brain metastases.","volume":"100","author":"Soliman","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"coi230020r12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0360-3016(99)00507-6","article-title":"Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05.","volume":"47","author":"Shaw","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"coi230020r13","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ijrobp.2019.10.002","article-title":"Nodular leptomeningeal disease\u2014a distinct pattern of recurrence after postresection stereotactic radiosurgery for brain metastases: a multi-institutional study of interobserver reliability.","volume":"106","author":"Turner","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"coi230020r14","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/neuonc\/noz049","article-title":"A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases.","volume":"21","author":"Prabhu","year":"2019","journal-title":"Neuro Oncol"},{"issue":"3","key":"coi230020r15","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ijrobp.2013.05.015","article-title":"Challenges with the diagnosis and treatment of cerebral radiation necrosis.","volume":"87","author":"Chao","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"446","key":"coi230020r17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"coi230020r18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10985-014-9313-9","article-title":"Checking Fine and Gray subdistribution hazards model with cumulative sums of residuals.","volume":"21","author":"Li","year":"2015","journal-title":"Lifetime Data Anal"},{"issue":"15","key":"coi230020r19","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Graphical methods for assessing violations of the proportional hazards assumption in Cox regression.","volume":"14","author":"Hess","year":"1995","journal-title":"Stat Med"},{"issue":"2","key":"coi230020r20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3171\/2014.10.JNS141610","article-title":"Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.","volume":"123","author":"Sneed","year":"2015","journal-title":"J Neurosurg"},{"issue":"2","key":"coi230020r21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ijrobp.2007.06.074","article-title":"A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.","volume":"70","author":"Sperduto","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"coi230020r22","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijrobp.2013.09.051","article-title":"A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases.","volume":"88","author":"Brennan","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"coi230020r23","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jamaoncol.2020.4630","article-title":"Multi-institutional analysis of prognostic factors and outcomes after hypofractionated stereotactic radiotherapy to the resection cavity in patients with brain metastases.","volume":"6","author":"Eitz","year":"2020","journal-title":"JAMA Oncol"},{"issue":"5","key":"coi230020r24","doi-asserted-by":"publisher","first-page":"E860","DOI":"10.1093\/neuros\/nyz162","article-title":"Image-guided, linac-based, surgical cavity\u2013hypofractionated stereotactic radiotherapy in 5 daily fractions for brain metastases.","volume":"85","author":"Soliman","year":"2019","journal-title":"Neurosurgery"},{"key":"coi230020r25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3171\/2014.6.GKS14708","article-title":"Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.","volume":"121","author":"Ojerholm","year":"2014","journal-title":"J Neurosurg"},{"issue":"1","key":"coi230020r26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijrobp.2020.08.013","article-title":"Single- and multifraction stereotactic radiosurgery dose\/volume tolerances of the brain.","volume":"110","author":"Milano","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"coi230020r27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ijrobp.2020.06.057","article-title":"Predictors of adverse radiation effect in brain metastasis patients treated with stereotactic radiosurgery and immune checkpoint inhibitor therapy.","volume":"108","author":"Helis","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"coi230020r28","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/CMR.0000000000000268","article-title":"BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis.","volume":"26","author":"Patel","year":"2016","journal-title":"Melanoma Res"},{"key":"coi230020r16","unstructured":"US National Library of Medicine. Comparing the addition of radiation either before or after surgery for patients with brain metastases. Accessed July 18, 2022. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05438212"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2805957\/jamaoncology_prabhu_2023_oi_230020_1691789044.36355.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T15:24:11Z","timestamp":1692285851000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2805957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2023.1629","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}